This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Under $10 Setting Up to Soar

Amicus Therapeutics

One name under-$10 stock in the biotechnology and drugs complex that's starting to look very bullish is Amicus Therapeutics (FOLD), which is focused on the discovery, development and commercialization of orally administered, small molecule drugs known as pharmacological chaperones for the treatment of rare diseases. This stock has been blazing a trail in 2012, with shares up over 38% so far.

If you take a look at the chart for Amicus Therapeutics, you'll notice that this stock has been soaring since it hit a bottom at $2.10 in late November of last year. This stock has soared so much that its current price is quickly approaching $5 a share. This big run up in the stock is now pushing shares of FOLD up against some key breakout levels, that if hit, could lead to much higher prices.

>>5 Stocks Poised to Break Out

Market players should now watch FOLD for a sustained high-volume move and close above $4.71 and $5.10 (200-day) a share to trigger a breakout trade. Look for volume that registers near or above its three-month average action of 58,210 shares. At last check, volume for FOLD has already hit 89,000 shares today with the stock trading at around $4.96 a share. This now puts FOLD within range of taking out $5.10, which would be very bullish price action.

You could be a buyer of FOLD off any weakness and simply use a mental stop that's just below $4.71 or that's near today's low of $4.34. You could also buy off strength if it takes out $5.10 soon, and simply use a mental stop right below that level. I would target a run back towards $6 to $7 a share, or possibly higher if we get a high-volume breakout over $5.10 for FOLD in the near future.
4 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
STP $0.53 0.00%
ASTI $0.05 -3.51%
FOLD $7.76 -0.32%
INFN $12.00 -22.90%
UEC $0.81 -5.20%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs